Successful treatment of multiple basaliomas with bleomycinbased electrochemotherapy: A case series of three patients with gorlin-goltz syndrome

Acta Dermato-Venereologica

Volumn 92, Issue 6, 2012, Pages 648-651

  Kis, Erika ^a   Baltás, Eszter ^a   Kinyó, Ágnes ^a   Varga, Erika ^a   Nagy, Nikoletta ^a   Gyulai, Rolland ^a   Kemény, Lajos ^a   Oláh, Judit ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Bleomyci; Electrochemotherapy; Gorlin goltz syndrome

Indexed keywords

BLEOMYCIN;

ADULT; ARTICLE; BASAL CELL CARCINOMA; BASAL CELL NEVUS SYNDROME; CANCER PATIENT; CANCER REGRESSION; CASE REPORT; ELECTRIC CURRENT; ELECTROCHEMOTHERAPY; ESTHETICS; FEMALE; HISTOLOGY; HUMAN; MALE; MEDICAL DEVICE; PRIORITY JOURNAL; RARE DISEASE; SCAR FORMATION; SYSTEMIC DISEASE; TREATMENT OUTCOME; TREATMENT RESPONSE; TUMOR ABLATION; TUMOR VOLUME; WOUND HEALING;

ANTIBIOTICS, ANTINEOPLASTIC; BASAL CELL NEVUS SYNDROME; BIOPSY; BLEOMYCIN; CICATRIX; ELECTROCHEMOTHERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT SATISFACTION; SKIN NEOPLASMS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84867835598     PISSN: 00015555     EISSN: 16512057     Source Type: Journal    
DOI: 10.2340/00015555-1361     Document Type: Article

References (26)

1. Johnson RL, Rothman AL, Xie J, Goodrich LV, Bare JW, Bonifas JM, et al. Human homolog of patched, a candidate gene for the basal cell nevus syndrome. Science 1996; 272: 1668-1671.
2. Smyth I, Narang MA, Evans T, Heimann C, Nakamura Y, Chenevix-Trench G, et al. Isolation and characterization of human patched 2 (PTCH2), a putative tumour suppressor gene inbasal cell carcinoma and medulloblastoma on chromosome 1p32. Hum Mol Genet 1999; 8: 291-297.
3. Pastorino L, Ghiorzo P, Nasti S, Battistuzzi L, Cusano R, Marzocchi C, et al. Identification of a SUFU germline mutation in a family with Gorlin syndrome. Am J Med Genet A 2009; 149A: 1539-1543.
4. Ljubenovic M, Ljubenovic D, Binic I, Jovanovic D, Stanojevic M. Gorlin-Goltz syndrome. Acta Dermatovenerol Alp Panonica Adriat 2007; 16: 166-169.
5. Mitropoulos P, Norman R. Nevoid basal cell carcinoma syndrome (Gorlin syndrome): updated review of minimally invasive treatments. Cutis 2008; 81: 53-60.
6. Stockfleth E, Ulrich C, Hauschild A, Lischner S, Meyer T, Christophers E. Successful treatment of basal cell carcinomas in a nevoid basal cell carcinoma syndrome with topical 5% imiquimod. Eur J Dermatol 2002; 12: 569-572.
7. Robarge KD, Brunton SA, Castanedo GM, Cui Y, Dina MS, Goldsmith R, et al. GDC-0449-a potent inhibitor of the hedgehog pathway. Bioorg Med Chem Lett 2009; 19: 5576-5581.
8. Kis E, Olah J, Ocsai H, Baltas E, Gyulai R, Kemeny L, et al. Electrochemotherapy of cutaneous metastases of melanoma-a case series study and systematic review of the evidence. Dermatol Surg 2011; 37: 816-824.
9. Mir LM, Glass LF, Sersa G, Teissie J, Domenge C, Miklavcic D, et al. Effective treatment of cutaneous and subcutaneous malignant tumours by electrochemotherapy. Br J Cancer 1998; 77: 2336-2342.
10. Heller R, Jaroszeski M, Perrott R, Messina J, Gilbert R. Effective treatment of B16 melanoma by direct delivery of bleomycin using electrochemotherapy. Melanoma Res 1997; 7: 10-18.
11. Glass LF, Fenske NA, Jaroszeski M, Perrott R, Harvey DT, Reintgen DS, et al. Bleomycin-mediated electrochemotherapy of basal cell carcinoma. J Am Acad Dermatol 1996; 34: 82-86.
12. Sersa G, Stabuc B, Cemazar M, Miklavcic D, Rudolf Z. Electrochemotherapy with cisplatin: clinical experience in malignant melanoma patients. Clin Cancer Res 2000; 6: 863-867.
13. Mir LM, Gehl J, Sersa G, Collins CG, Garbay JR, Billard V, et al. Standard operating procedures of the electrochemotherapy: Instructions for the use of bleomycin or cisplatin administered either systemically or locally and electric pulses delivered by the Cliniporator (TM) by means of invasive or non-invasive electrodes. EJC Supplements 2006; 4: 14-25.
14. Marty M, Sersa G, Garbay JR, Gehl J, Collins CG, Snoj M, et al. Electrochemotherapy - An easy, highly effective and safe treatment of cutaneous and subcutaneous metastases: Results of ESOPE (European Standard Operating Procedures of Electrochemotherapy) study. EJC Supplements 2006; 4: 3-13.
15. Domenge C, Orlowski S, Luboinski B, De Baere T, Schwaab G, Belehradek J Jr, et al. Antitumor electrochemotherapy: new advances in the clinical protocol. Cancer 1996; 77: 956-963.
16. WHO. Handbook for reporting results of cancer treatment. Geneva: World Health Organization, 1997: p. 22-27.
17. Campana LG, Mocellin S, Basso M, Puccetti O, De Salvo GL, Chiarion-Sileni V, et al. Bleomycin-based electrochemotherapy: clinical outcome from a single institution's experience with 52 patients. Ann Surg Oncol 2009; 16: 191-199.
18. Tounekti O, Kenani A, Foray N, Orlowski S, Mir LM. The ratio of single- to double-strand DNA breaks and their absolute values determine cell death pathway. Br J Cancer 2001; 84: 1272-1279.
19. Mir LM, Tounekti O, Orlowski S. Bleomycin: revival of an old drug. Gen Pharmacol 1996; 27: 745-748.
20. Tounekti O, Pron G, Belehradek J Jr, Mir LM. Bleomycin, an apoptosis-mimetic drug that induces two types of cell death depending on the number of molecules internalized. Cancer Res 1993; 53: 5462-5469.
21. Muraoka Y, Takita T. Bleomycins. Cancer Chemother Biol Response Modif 1990; 11: 58-66.
22. Glass LF, Jaroszeski M, Gilbert R, Reintgen DS, Heller R. Intralesional bleomycin-mediated electrochemotherapy in 20 patients with basal cell carcinoma. J Am Acad Dermatol 1997; 37: 596-599.
23. Heller R, Jaroszeski MJ, Reintgen DS, Puleo CA, DeConti RC, Gilbert RA, et al. Treatment of cutaneous and subcutaneous tumors with electrochemotherapy using intralesional bleomycin. Cancer 1998; 83: 148-157.
24. Rodriguez-Cuevas S, Barroso-Bravo S, Almanza-Estrada J, Cristobal-Martinez L, Gonzalez-Rodriguez E. Electrochemotherapy in primary and metastatic skin tumors: phase II trial using intralesional bleomycin. Arch Med Res 2001; 32: 273-276.
25. Landström FJ, Nilsson CO, Crafoord S, Reizenstein JA, Adamsson GB, Löfgren LA. Electroporation therapy of skin cancer in the head and neck area. Dermatol Surg 2010; 36: 1245-1250.
26. Colombo GL, Matteo SD, Mir LM. Cost-effectiveness analysis of electrochemotherapy with the Cliniporator trade mark vs other methods for the control and treatment of cutaneous and subcutaneous tumors. Ther Clin Risk Manage 2008; 4: 541-548.